Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study

Ermis, O; Alpsoy, ERKAN; Cetin, L; Yilmaz, ERTAN

doi:10.1046/j.1365-2133.2001.04286.x

Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study

Ermis O., Alpsoy E., Cetin L., Yilmaz E.

BRITISH JOURNAL OF DERMATOLOGY, vol.145, no.3, pp.472-475, 2001 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 145 Issue: 3
Publication Date: 2001
Doi Number: 10.1046/j.1365-2133.2001.04286.x
Journal Name: BRITISH JOURNAL OF DERMATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.472-475
Keywords: calcipotriol, psoralen plus ultraviolet A therapy, randomized controlled trial, vitiligo, CALCIUM, COMBINATION
Akdeniz University Affiliated: Yes

Abstract

Background Encouraging results of previous uncontrolled trials suggest that calcipotriol may potentiate the efficacy of psoralen plus ultraviolet (UV) A (PUVA) therapy in patients with vitiligo.